SGHT
Sight Sciences, Inc. · Healthcare
Director Staffan Encrantz bought $69K of Sight Sciences, Inc.
Bought$68,794
$4.88Price
14,100Shares
+1%Stake
What SGHT did for a copier
- $1,000 copied at Fri, Jun 12 open, $4.89
- $1,084
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Jul 28 close.
Staffan Encrantz's record
8 other buys with 3 months of prices since 2021: on average −15.2% against the S&P 500, and 2 of 8 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jun 10. Filed Thu, Jun 11, 4:43 PM ET, after the close. Returns use the Jun 12 open and the Jul 28 close. Not investment advice.